Between 2013 and 2023, the per capita market size for hormones in dosage forms, excluding contraceptives and antibiotics, in New Zealand showed fluctuation. Starting at $31.74 in 2013, it hit a low in 2015 with $27.76. A slight recovery was seen till 2021 at $31.32, but by 2023, it slightly decreased to $28.41. This results in a year-on-year decrease of around 10% from 2021 to 2023. The 5-year CAGR shows a minor decline, suggesting shrinkage in per capita expenditure.

Future trends to watch include:

Potential growth in demand due to demographic changes.
Innovations in hormone therapies may influence market expansion.
Healthcare policy shifts affecting prescription patterns and expenditure levels.